Clinical results of SilveRpès on cysts

Average count of cysts after 10 days of daily use among volunteers using SilveRpès  or the placebo:

• At D1, the results obtained demonstrate that the average count of cysts is higher among the volunteers having used the placebo than among the volunteers who used SilveRpès  (respective counts of 0.8 and 0.6);
• Among the group testing SilveRpès, the cysts were reduced from D2 to totally disappear on D5; for the group testing the placebo, the cysts also reduced from D2 and disappear only on D7;
• 23% of the volunteers produced no cysts (aborted onset) in the SilveRpès group; in the placebo group, 15% of the volunteers presented no cysts during the study.